Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings

Andrea De Luca, Andrew Phillips, Valentina Cambiano, Fumiyo Nakagawa, Travor Magubu, Alec Miners, Debbie Ford, Deenan Pillay, Jens Lundgren, Paul Revill

Risultato della ricerca: Contributo in rivistaArticolo in rivista

22 Citazioni (Scopus)

Abstract

To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified.
Lingua originaleEnglish
pagine (da-a)e109148-e109148
RivistaPLoS One
Volume9
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • HIV
  • cost
  • therapy

Fingerprint Entra nei temi di ricerca di 'Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings'. Insieme formano una fingerprint unica.

Cita questo